We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+4.36%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$141M
AUM Growth
-$8.84M
Cap. Flow
-$2.61M
Cap. Flow %
-1.86%
Top 10 Hldgs %
38.31%
Holding
78
New
15
Increased
12
Reduced
33
Closed
3

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.25M
2
RYN icon
Rayonier
RYN
+$2.86M
3
CVX icon
Chevron
CVX
+$200K
4
AGN.PRA
Allergan plc
AGN.PRA
+$200K
5
MRK icon
Merck
MRK
+$189K

Top Sells

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$2.68M
2
SHPG
Shire pic
SHPG
+$2.67M
3
MDT icon
Medtronic
MDT
+$2.38M
4
BP icon
BP
BP
+$593K
5
BMO icon
Bank of Montreal
BMO
+$367K

Sector Composition

Rank Sector Weight
1 Financials 20.28%
2 Technology 17.51%
3 Healthcare 16.65%
4 Industrials 10.72%
5 Communication Services 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
26
Gilead Sciences
GILD
$161B
$2.6M 1.85%
36,255
-2,470
-6% -$184K
LYB icon
27
LyondellBasell Industries
LYB
$19.5B
$2.46M 1.75%
28,670
+1,850
+7% +$155K
EMR icon
28
Emerson Electric
EMR
$82.9B
$2.32M 1.65%
41,685
-3,735
-8% -$201K
SRCL
29
DELISTED
Stericycle Inc
SRCL
$2.16M 1.54%
28,075
-3,020
-10% -$228K
CI icon
30
Cigna
CI
$76.6B
$2.12M 1.51%
15,870
-542
-3% -$70.9K
BCE icon
31
BCE
BCE
$19.9B
$1.89M 1.34%
43,617
-100
-0.2% -$4.41K
XOM icon
32
ExxonMobil
XOM
$651B
$1.56M 1.11%
17,247
-470
-3% -$41.1K
MDT icon
33
Medtronic
MDT
$107B
$1.38M 0.98%
19,383
-30,304
-61% -$2.38M
RAI
34
DELISTED
Reynolds American Inc
RAI
$1.36M 0.97%
24,310
– –
EFA icon
35
iShares MSCI EAFE ETF
EFA
$76.4B
$1.25M 0.89%
21,570
+500
+2% +$28.8K
V icon
36
Visa
V
$677B
$1.24M 0.88%
15,825
+38
+0.2% +$3.06K
FTV icon
37
Fortive
FTV
$19B
$1.01M 0.72%
29,949
-1,056
-3% -$34.9K
NVO
38
Novo Nordisk
NVO
$216B
$871K 0.62%
48,598
-800
-2% -$14.5K
AGN.PRA
39
DELISTED
Allergan plc
AGN.PRA
$850K 0.6%
1,117
+265
+31% +$200K
SRCLP
40
DELISTED
Stericycle, Inc
SRCLP
$823K 0.59%
13,000
+1,010
+8% +$64K
VFC icon
41
VF Corp
VFC
$6.68B
$820K 0.58%
16,314
-279
-2% -$14.5K
EEM icon
42
iShares MSCI Emerging Markets ETF
EEM
$28B
$729K 0.52%
20,812
– –
MSFT icon
43
Microsoft
MSFT
$2.84T
$723K 0.51%
11,634
-600
-5% -$36.1K
SLB icon
44
SLB Ltd
SLB
$77.8B
$697K 0.5%
8,300
– –
SHW icon
45
Sherwin-Williams
SHW
$78.3B
$670K 0.48%
7,482
– –
ORCL icon
46
Oracle
ORCL
$331B
$490K 0.35%
12,740
– –
ETN icon
47
Eaton
ETN
$157B
$392K 0.28%
5,845
+1,100
+23% +$72.2K
JNJ icon
48
Johnson & Johnson
JNJ
$635B
$371K 0.26%
3,223
-100
-3% -$11.6K
CBU icon
49
Community Bank
CBU
$3.53B
$350K 0.25%
5,667
– –
ABBV icon
50
AbbVie
ABBV
$458B
$345K 0.25%
5,510
– –
1
2
3 4

Similar funds

VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return

Lipe & Dalton's Q4 2016 Portfolio in Review

As of Q4 2016, Lipe & Dalton held 78 positions worth $141M, down 5.9% from $149M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Lipe & Dalton's Q4 2016 filing shows 15 new, 12 increased, 33 reduced and 3 closed positions. Its largest new stake was Bristol-Myers Squibb: 59,449 shares worth $3.47M. The largest sale was Devon Energy, an estimated $2.68M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • Lipe & Dalton's largest Q4 2016 buy was Bristol-Myers Squibb: 59,449 shares worth $3.47M.
  • Lipe & Dalton added most to Allergan plc in Q4 2016, an estimated $200K increase.
  • Lipe & Dalton's biggest Q4 2016 reduction was Medtronic, cutting an estimated $2.38M.
  • Lipe & Dalton fully exited Devon Energy in Q4 2016, selling an estimated $2.68M.
  • Lipe & Dalton's ten largest holdings make up 38% of its $141M portfolio in Q4 2016.
  • Lipe & Dalton opened 15 new positions and closed 3 in Q4 2016.
  • Lipe & Dalton's portfolio value fell 5.9% quarter-over-quarter to $141M.

Based on Lipe & Dalton's 13F filing for Q4 2016, filed 10 Feb 2017.